Park Annual 16

Did you miss the event or want to share the seminars? Take a look at the films below! The innovation event Park Annual attracted 500 life science delegates this year. The exciting mix of presentations highlighted the strong growth potential in the region.

Digital Health

How to transform health care and save life


Daniel Eliasson, co-founder & CEO, Gnosco

The human flourishing platformThe human flourishing platform


Pål Dobrin, Creative director at Empaticus

Entrepreneurial Journey Destination Digital Health


Björn Stansvik, MentorMate

Medtech

A novel approach to assessment of peripheral nerve injury


Louise Warme, CEO & co founder LARA Diagnostics

Innovation to realisation in practice- Opportunities for SMEs


Keith Heaton, MD, I2R Medical Ltd

360 million lives: diagnosing and preventing hearing loss with your smartphone


Mike Pallett, CEO Cupris Health

Bringing innovative products to the UK and National Health Service (NHS)


Fay McCracken, Adviser, Office for Market Access & Technology Appraisals, CHTE, NICE

More than Patient Monitoring – Data driven digital healthcare


Keith Errey, CEO Isansys ”21st century medical devices and new patient pathways”

The future of medical research


Erik Gatenholm, co-Founder & CEO, CELLINK

Pharma

Developing a new therapeutic approach to prevent thrombosis


Sten R. Sörensen, CEO, Cereno Scientific

From idea to reality – how hard can it be?


Lars Backsell, CEO, Recipharm AB (publ) ”All companies or products have their beginning in an idea – sometimes quite simple ideas become large companies or global products”

Outmaneuvering antibiotic resistance with virulence blockers


Fritiof Pontén, CEO, QuretechBio ”New treatment approaches targeting Tuberculosis and Gram positive HAI infections by restoring antibiotic susceptibility”

Growth

The competitive future – from a European Perspective


Alexander Schenk, Head of Stockholm Office European Investment Bank Group

Venture Capital financing of life science companies in the Nordic region


Nina Rawal, Head of Life Science, Industrifonden

Growth & development from a company group perspective


Artur Aira, COO, Executive Vice President

Introductions and summaries

Opening remarks


Charlotta Gummeson, CEO Sahlgrenska Science Park

Introduction to session 1


Moderator Magnus Björsne, CEO, AstraZeneca BioVentureHub

Introduction to session 2


Moderator Magnus Björsne, CEO, AstraZeneca BioVentureHub

Introduction to sesion 3


Moderator Magnus Björsne, CEO, AstraZeneca BioVentureHub

Closing of Park Annual sessions


Charlotta Gummeson, CEO, Sahlgrenska Science Park